ArriVent Appoints John Hohneker, M.D., to its Board of Directors
NEWTON SQUARE, Pa., May 16, 2024 (GLOBE NEWSWIRE) — ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global […]
ZimVie to Participate in Upcoming Investor Conferences
PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) — ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in […]
Merit Medical Shareholders Elect Silvia M. Perez as New Director
SOUTH JORDAN, Utah, May 16, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare […]
Earlyworks Announces Completion of ADS Ratio Change
TOKYO, May 16, 2024 (GLOBE NEWSWIRE) — Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating […]
Option Care Health to Participate in Upcoming Investor Conferences
BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest […]
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and […]
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on […]
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on […]
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) — Roivant (Nasdaq: ROIV) today announced that it […]
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
Boston, May 16, 2024 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announced its Co-CEO […]
